There are now 4 papers on the topic, where the evidence suggests, but does not prove, aspirin may reduce risk of future CVD events in patients with elevated Lp(a). However, they need validation in studies where aspirin was randomized at entry in modern cohorts. ASPREE did not…

👉 Aspirin Use for Primary Prevention Among US Adults With and Without Elevated Lp(a)

☝️Regular aspirin use was associated with a 52% lower risk of ASCVD mortality among adults without clinical ASCVD who had elevated Lp(a).
These findings suggest that measurement of Lp(a) may…

Congratulations Alexander C. Razavi!

Adding to the growing evidence base for aspirin in primary prevention with elevated Lp(a)

Just released ONLINE: #Association between #LPA and #T2D : A #Mendelian #Randomization #Study .

Based on the genetic data of over 0.5 milion patients we showed no causal association between Lp(a) levels and the #risk of #diebetes .

More data on this on the #ESCCongress2024 in…

This is now a hot topic, first presented by our group in collaboration with ASPREE. The idea was: is there a subgroup of pts without a prior CVD event that might benefit. The answer is yes, those with a specific genetic variant in LPA gene called rs3798220-C. This is associated…

Great job Gurleen Kaur, MD!

To all those gathering around the world in celebration of Vaisakhi, Navratri, Songkran, and the incoming New Year this week, Jill and I wish you warmth, community, and joy.

Happy Bengali, Khmer, Lao, Myanmarese, Nepali, Sinhalese, Tamil, Thai, and Vishu New Year!